Evolving regulatory perspectives on digital health technologies for medicinal product development

Evolving regulatory perspectives on digital health technologies for medicinal product development

Abstract Digital health technology tools (DHTTs) present real opportunities for accelerating innovation, improving patient care, reducing clinical trial duration and minimising risk in medicines development. This review is comprised of four case studies of DHTTs used throughout the lifecycle of medi...

Full description

Bibliographic Details
Main Authors: Seya Colloud, Thomas Metcalfe, Scott Askin, Shibeshih Belachew, Johannes Ammann, Ernst Bos, Timothy Kilchenmann, Paul Strijbos, Damien Eggenspieler, Laurent Servais, Chloé Garay, Athanasios Konstantakopoulos, Armin Ritzhaupt, Thorsten Vetter, Claudia Vincenzi, Francesca Cerreta
Format: Article
Language:English
Published: Nature Portfolio 2023-03-01
Series:npj Digital Medicine
Online Access:https://doi.org/10.1038/s41746-023-00790-2

Internet

https://doi.org/10.1038/s41746-023-00790-2

Similar Items